Efficacy and Safety of USL for Dry Eye Disease
NCT06016010 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2023-09-11
Summary
The objective is to compare the USL and placebo in terms of efficacy and safety, and to determine the appropriate dosage.
Conditions
Interventions
- DRUG
-
USL
500mg of Achyranthis Radix Extract
- DRUG
-
USL Placebo
USL Placebo
Sponsors & Collaborators
-
Chan-Sik Kim
lead OTHER_GOV
Principal Investigators
-
Chan-Sik Kim, PhD · Korea Institute of Oriental Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
More Related Trials
-
The Effect of Oral Zanthoxylum Schinifolium Seed Oil in Individuals With Dry Eye Disease
NCT02802150 ·Status: COMPLETED ·Phase: NA
-
YM-101 Eye Drops in the Treatment of Dry Eye Syndrome
NCT06792903 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers
NCT01162954 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
NCT01562795 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
NCT05865457 ·Status: RECRUITING ·Phase: NA
-
Study of TOP1630 for Dry Eye Syndrome
NCT03833388 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser Epithelial Keratomileusis (LASEK) Surgery
NCT06120348 ·Status: RECRUITING ·Phase: NA
-
Clinical Study Aimed At Evaluating the Safety and Efficacy of Tear Substitute Formulations in the Treatment of Dry Eye Disease.
NCT06633471 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops
NCT06209203 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
NCT05403827 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome
NCT02917512 ·Status: COMPLETED ·Phase: PHASE2
-
Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment of Dry Eye Disease
NCT07298811 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
NCT02815293 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients
NCT06337981 ·Status: COMPLETED ·Phase: PHASE2
-
[KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome
NCT05017844 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
NCT02958514 ·Status: COMPLETED ·Phase: NA
-
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01692145 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT02242032 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02824913 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease
NCT06188260 ·Status: COMPLETED ·Phase: PHASE2
-
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
NCT05759208 ·Status: COMPLETED ·Phase: PHASE2